Mitochondrial DNA Damage as a Mechanism of Cell Loss in Alzheimer's Disease

• Published in: Laboratory investigation Vol. 80; no. 8; pp. 1323 - 1335
• Main Authors: DE LA MONTE, S. M, TRI LUONG, NEELY, T. R, ROBINSON, D, WANDS, J. R
• Format: Journal Article
• Language: English
• Published: New York, NY Nature Publishing 01.08.2000; Nature Publishing Group
• Subjects: 8-Hydroxy-2'-Deoxyguanosine; Aged; Aged, 80 and over; Aging - pathology; Alzheimer Disease - genetics; Alzheimer Disease - pathology; Apoptosis; Base Sequence; Biological and medical sciences; Deoxyguanosine - analogs & derivatives; Deoxyguanosine - metabolism; Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes; DNA Damage; DNA Primers; DNA, Mitochondrial - genetics; Humans; Medical sciences; Nervous system (semeiology, syndromes); Neurology; Neurons - enzymology; Neurons - metabolism; Prostaglandin-Endoperoxide Synthases - metabolism; Human; Temporal lobe; Nervous system diseases; Alzheimer disease; Pathogenesis; Mitochondrial DNA; Cerebral disorder; Fragmentation; Cell death; Central nervous system disease; Chromosome DNA; Degenerative disease; Apoptosis
• ISSN: 0023-6837; 1530-0307
• DOI: 10.1038/labinvest.3780140

Aging is associated with impaired mitochondrial function caused by accumulation of oxygen free radical-induced mitochondrial (Mt) DNA mutations. One prevailing theory is that age-associated diseases, including Alzheimer's disease (AD), may be precipitated, propagated, or caused by impaired mitochondrial function. To investigate the role of MtDNA relative to genomic (Gn) DNA damage in AD, temporal lobe samples from postmortem AD (n = 37) and control (n = 25) brains were analyzed for MtDNA and GnDNA fragmentation, mitochondrial protein and cytochrome oxidase expression, MitoTracker Green fluorescence (to assess mitochondrial mass/abundance), and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-OHdG) immunoreactivity. Brains with AD had more extensive nicking and fragmentation of both MtDNA and GnDNA as demonstrated by agarose gel electrophoresis, end-labeling, and the in situ terminal deoxynucleotide transferase end-labeling (TUNEL) assay, and only the brains with AD had detectable 8-OHdG immunoreactivity in cortical neurons. Increased MtDNA damage in AD was associated with reduced MtDNA content, as demonstrated by semiquantitative PCR analysis and reduced levels of Mt protein and cytochrome oxidase expression by Western blot analysis or immunohistochemical staining with image analysis. The finding of reduced MitoTracker Green fluorescence in AD brains provided additional evidence that reduced Mt mass/abundance occurs with AD neurodegeneration. The presence of increased MtDNA and GnDNA damage in AD suggest dual cell death cascades in AD. Impaired mitochondrial function caused by MtDNA damage may render brain cells in AD more susceptible to oxidative injury and thereby provide a mechanism by which systemic or environmental factors could influence the course of disease.